Pharmacy Discipline, School of Clinical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD 4000, Australia.
School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD 4000, Australia.
Int J Mol Sci. 2023 Feb 25;24(5):4532. doi: 10.3390/ijms24054532.
The bactericidal effects of inhalable ciprofloxacin (CIP) loaded-poly(2-ethyl-2-oxazoline) (PEtOx) nanoparticles (NPs) with traces of zinc oxide (ZnO) were investigated against clinical strains of the respiratory pathogens and CIP-loaded PEtOx NPs retained their bactericidal activity within the formulations compared to free CIP drugs against these two pathogens, and bactericidal effects were enhanced with the inclusion of ZnO. PEtOx polymer and ZnO NPs did not show bactericidal activity alone or in combination against these pathogens. The formulations were tested to determine the cytotoxic and proinflammatory effects on airway epithelial cells derived from healthy donors (NHBE), donors with chronic obstructive pulmonary disease (COPD, DHBE), and a cell line derived from adults with cystic fibrosis (CFBE41o-) and macrophages from healthy adult controls (HCs), and those with either COPD or CF. NHBE cells demonstrated maximum cell viability (66%) against CIP-loaded PEtOx NPs with the half maximal inhibitory concentration (IC) value of 50.7 mg/mL. CIP-loaded PEtOx NPs were more toxic to epithelial cells from donors with respiratory diseases than NHBEs, with respective IC values of 0.103 mg/mL for DHBEs and 0.514 mg/mL for CFBE41o- cells. However, high concentrations of CIP-loaded PEtOx NPs were toxic to macrophages, with respective IC values of 0.002 mg/mL for HC macrophages and 0.021 mg/mL for CF-like macrophages. PEtOx NPs, ZnO NPs, and ZnO-PEtOx NPs with no drug were not cytotoxic to any cells investigated. The in vitro digestibility of PEtOx and its NPs was investigated in simulated lung fluid (SLF) (pH 7.4). The analysed samples were characterized using Fourier transform infrared spectroscopy (ATR-FTIR), scanning electron microscopy (SEM), and UV-Vis spectroscopy. Digestion of PEtOx NPs commenced one week following incubation and was completely digested after four weeks; however, the original PEtOx was not digested after six weeks of incubation. The outcome of this study revealed that PEtOx polymer could be considered an efficient drug delivery carrier in respiratory linings, and CIP-loaded PEtOx NPs with traces of ZnO could be a promising addition to inhalable treatments against resistant bacteria with reduced toxicity.
研究了载有痕量氧化锌 (ZnO) 的可吸入环丙沙星 (CIP) 负载聚 (2-乙基-2-恶唑啉) (PEtOx) 纳米颗粒 (NPs) 对临床呼吸道病原体的杀菌作用,与游离 CIP 药物相比,CIP 负载的 PEtOx NPs 在制剂中保留了杀菌活性,并且包含 ZnO 可增强杀菌作用。PEtOx 聚合物和 ZnO NPs 单独或联合使用对这些病原体均无杀菌活性。对来自健康供体 (NHBE)、慢性阻塞性肺疾病 (COPD、DHBE) 供体和囊性纤维化 (CFBE41o-) 衍生的成人细胞系以及来自健康成人对照 (HCs) 的巨噬细胞的气道上皮细胞进行了制剂测试,以确定细胞毒性和促炎作用,以及那些患有 COPD 或 CF 的患者。NHBE 细胞对载有 CIP 的 PEtOx NPs 的细胞活力最高 (66%),半数最大抑制浓度 (IC) 值为 50.7mg/mL。载有 CIP 的 PEtOx NPs 对患有呼吸道疾病的供体上皮细胞的毒性大于 NHBEs,DHBEs 的 IC 值分别为 0.103mg/mL,CFBE41o-细胞的 IC 值分别为 0.514mg/mL。然而,高浓度的载有 CIP 的 PEtOx NPs 对巨噬细胞有毒,HC 巨噬细胞的 IC 值分别为 0.002mg/mL,CF 样巨噬细胞的 IC 值分别为 0.021mg/mL。没有药物的 PEtOx NPs、ZnO NPs 和 ZnO-PEtOx NPs 对所有研究的细胞均无细胞毒性。在模拟肺液 (SLF) (pH7.4) 中研究了 PEtOx 及其 NPs 的体外消化情况。使用傅里叶变换红外光谱 (ATR-FTIR)、扫描电子显微镜 (SEM) 和紫外可见光谱对分析样品进行了表征。PEtOx NPs 的消化在孵育一周后开始,并在四周后完全消化;然而,原始的 PEtOx 在孵育六周后仍未消化。这项研究的结果表明,PEtOx 聚合物可被视为呼吸衬里中有效的药物输送载体,并且载有痕量 ZnO 的 CIP 负载的 PEtOx NPs 可能是一种有前途的添加物,可用于治疗具有降低毒性的耐药菌的吸入治疗。